[dsm_breadcrumbs items_bg_color="RGBA(0,0,0,0)" separator_bg_color="RGBA(0,0,0,0)" current_bg_color="RGBA(0,0,0,0)" _builder_version="4.9.2" _module_preset="default" items_text_color="#123675" home_icon_text_color="#123675" separators_text_color="#123675" current_text_color="#123675" background_color="RGBA(0,0,0,0)" custom_margin="||||false|false" custom_padding="||||false|false" border_color_all_items="RGBA(0,0,0,0)"][/dsm_breadcrumbs]

ABX-CRO at TRP 2022

This year we will be hosting partner at the 4th annual Targeted Radiopharmaceuticals Summit Europe. Meet ABX-CRO at the TRP 2022 Dec 6-8 | Amsterdam, Netherlands.

read more


Meet ABX-CRO executives at the SNMMI 2022 Annual Meeting June 11-14 | Vancouver, BC, at booth no. # 649. Celebrate with us our inauguration of our Boston-based US branch ABX-CRO Inc., further strengthening our global operations,...

read more

Andreas Fintelmann joins ABX-CRO as Managing Director

Andreas Fintelmann, leading radiopharmaceutical and precursor industry expert and executive joins ABX-CRO as managing director to support the further global expansion and growth of ABX-CRO. Andreas Fintelmann states “I am delighted to join ABX-CRO and reunite with...

read more

New Alliance: DRIVE™-MRT

ABX-CRO (Dresden, Germany), the globally leading full-service CRO for molecular imaging and radiotherapy, ONCODESIGN (ALONC -FR0011766229), a French biopharmaceutical company dedicated to precision medicine, Covalab (Bron, France), a biotechnology company specializing in the development and production of custom antibodies and CheMatech (Dijon, France), the European leader in the design announce their partnership. This strategic collaboration will launch the DRIVE™-MRT (Molecular RadioTherapy) solution. This innovative, premium service offer for therapeutic development is unique in nuclear medicine; it encompasses the full drug discovery process of theranostics, from therapeutic target validation, radiolabeled biological vector generation, lead optimization, preclinical candidate drug generation and IND, to the design and management of clinical trials.

read more